tiprankstipranks
Trending News
More News >
Cyclacel Pharmaceuticals (CYCC)
:CYCC
US Market
Advertisement

Cyclacel Pharmaceuticals (CYCC) Ratios

Compare
778 Followers

Cyclacel Pharmaceuticals Ratios

CYCC's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, CYCC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.60 0.91 3.30 7.73 14.27
Quick Ratio
5.60 0.91 4.07 7.62 13.99
Cash Ratio
5.20 0.41 2.48 6.91 13.44
Solvency Ratio
-12.42 -2.75 -1.77 -3.54 -2.38
Operating Cash Flow Ratio
-11.33 -1.97 -2.82 -3.50 -3.19
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 3.04M$ -754.00K$ 12.42M$ 35.62M$ 31.93M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.03
Debt-to-Equity Ratio
<0.01 0.06 <0.01 <0.01 0.03
Debt-to-Capital Ratio
<0.01 0.06 <0.01 <0.01 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.22 14.51 1.77 1.14 1.11
Debt Service Coverage Ratio
-475.29 0.00 0.00 0.00 0.00
Interest Coverage Ratio
-453.04 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.02 0.16 0.05 4.36
Net Debt to EBITDA
0.27 0.13 0.66 1.61 3.05
Profitability Margins
Gross Profit Margin
128.57%100.00%0.00%0.00%0.00%
EBIT Margin
60666.67%-6060.24%0.00%0.00%0.00%
EBITDA Margin
60647.62%-6052.86%0.00%0.00%0.00%
Operating Profit Margin
60404.76%-6060.24%0.00%0.00%0.00%
Pretax Profit Margin
37023.81%-6083.57%0.00%0.00%0.00%
Net Profit Margin
39747.62%-5370.24%0.00%0.00%0.00%
Continuous Operations Profit Margin
39747.62%-5370.24%0.00%0.00%0.00%
Net Income Per EBT
107.36%88.27%81.80%83.08%87.23%
EBT Per EBIT
61.29%100.39%93.70%99.11%91.02%
Return on Assets (ROA)
-223.54%-256.16%-77.08%-44.35%-22.95%
Return on Equity (ROE)
-3641.00%-3715.82%-136.68%-50.69%-25.39%
Return on Capital Employed (ROCE)
-413.06%-3952.33%-137.53%-61.51%-30.99%
Return on Invested Capital (ROIC)
-443.45%-3488.90%-112.50%-51.10%-27.04%
Return on Tangible Assets
-223.54%-256.16%-77.08%-44.35%-22.95%
Earnings Yield
-19.46%-31.03%-322.19%-54.39%-29.76%
Efficiency Ratios
Receivables Turnover
0.00 0.14 0.00 0.00 0.00
Payables Turnover
0.05 0.00 0.01 0.02 0.04
Inventory Turnover
0.00 0.00 >-0.01 0.07 0.03
Fixed Asset Turnover
-1.05 4.12 0.00 0.00 0.00
Asset Turnover
>-0.01 0.05 0.00 0.00 0.00
Working Capital Turnover Ratio
-0.09 0.05 0.00 0.00 0.00
Cash Conversion Cycle
-6.93K 2.55K -93.54K -13.07K 3.10K
Days of Sales Outstanding
0.00 2.55K 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 -64.33K 4.90K 12.48K
Days of Payables Outstanding
6.93K 0.00 29.21K 17.97K 9.38K
Operating Cycle
0.00 2.55K -64.33K 4.90K 12.48K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.58 -9.47 -31.67 -31.16 -32.75
Free Cash Flow Per Share
-0.58 -9.47 -31.68 -31.20 -33.15
CapEx Per Share
0.00 <0.01 0.01 0.05 0.40
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
0.00 -77.84 -100.13 -81.32 -26.71
Capital Expenditure Coverage Ratio
0.00 -2.69K -2.98K -686.67 -82.65
Operating Cash Flow Coverage Ratio
-834.47 -435.46 -196.48 -618.00 -7.51
Operating Cash Flow to Sales Ratio
357.63 -38.36 0.00 0.00 0.00
Free Cash Flow Yield
-9.55%-22.17%-316.65%-53.47%-28.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.14 -3.22 -0.31 -1.84 -3.36
Price-to-Sales (P/S) Ratio
-3.74K 173.08 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
14.01 119.76 0.42 0.93 0.85
Price-to-Free Cash Flow (P/FCF) Ratio
-10.47 -4.51 -0.32 -1.87 -3.53
Price-to-Operating Cash Flow Ratio
-5.71 -4.51 -0.32 -1.87 -3.58
Price-to-Earnings Growth (PEG) Ratio
-0.12 0.52 -0.20 0.21 0.04
Price-to-Fair Value
14.01 119.76 0.42 0.93 0.85
Enterprise Value Multiple
-5.90 -2.73 0.42 0.08 0.37
Enterprise Value
75.20M 69.35M -11.66M -1.81M -3.97M
EV to EBITDA
-5.90 -2.73 0.42 0.08 0.37
EV to Sales
-3.58K 165.13 0.00 0.00 0.00
EV to Free Cash Flow
-10.01 -4.30 0.56 0.10 0.49
EV to Operating Cash Flow
-10.01 -4.30 0.56 0.10 0.50
Tangible Book Value Per Share
0.24 0.36 23.58 62.62 137.31
Shareholders’ Equity Per Share
0.24 0.36 23.58 62.62 137.31
Tax and Other Ratios
Effective Tax Rate
-0.07 0.12 0.18 0.17 0.13
Revenue Per Share
>-0.01 0.25 0.00 0.00 0.00
Net Income Per Share
-0.64 -13.25 -32.23 -31.74 -34.86
Tax Burden
1.07 0.88 0.82 0.83 0.87
Interest Burden
0.61 1.00 0.94 1.00 0.91
Research & Development to Revenue
-222.57 45.61 0.00 0.00 0.00
SG&A to Revenue
-382.10 16.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
-18.60 3.51 0.00 0.00 0.00
Income Quality
0.91 0.71 0.98 0.98 0.94
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis